3-[(4-fluoro-3-methylphenyl)amino]-7-phenyl-2-(piperidin-4-ylcarbonyl)-thieno[2,3-b]pyridin-6(7H)-one

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩并吡啶类
• 英文名称: 3-[(4-fluoro-3-methylphenyl)amino]-7-phenyl-2-(piperidin-4-ylcarbonyl)-thieno[2,3-b]pyridin-6(7H)-one
• 英文别名: 3-(4-Fluoro-3-methylanilino)-7-phenyl-2-(piperidine-4-carbonyl)thieno[2,3-b]pyridin-6-one
• 化学式: C₂₆H₂₄FN₃O₂S
• 分子量: 461.56
• InChiKey: ATGJHQBFKQTZNK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  33
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  89.7
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  3-[(4-fluoro-3-methylphenyl)amino]-7-phenyl-2-(piperidin-4-ylcarbonyl)-thieno[2,3-b]pyridin-6(7H)-one 、 聚合甲醛 在 sodium cyanoborohydride 作用下， 以 甲醇 为溶剂， 反应 24.0h， 生成 3-[(4-fluoro-3-methylphenyl)amino]-2-[(1-methylpiperidin-4-yl)carbonyl]-7-phenylthieno[2,3-b]pyridin-6(7H)-one
  参考文献：
  名称：

  [EN] THIENOPYRIDONE DERIVATIVES AS KINASE INHIBITORS
  [FR] DERIVES DE THIENOPYRIDONE EN TANT QU'INHIBITEURS DE KINASE

  摘要：

  一系列在2位被羰基或磺酰基连接的吡咯烷-3-基、吡咯烷-3-氨基或相关基团取代的噻吩[2,3-b]吡啶-6(7H)-酮衍生物，作为p38 MAP激酶的抑制剂，在医学上具有用途，例如在治疗和/或预防免疫或炎症性疾病方面。

  公开号：

  WO2004113348A1

文献信息

• Thienopyridone derivatives as kinase inhibitors
  申请人：Brookings Christopher Daniel

  公开号：US20060247269A1

  公开（公告）日：2006-11-02

  A series of thieno[2,3-b]pyridin-6(7H)-one derivatives, substituted in the 2-position by a carbonyl- or sulfonyl-linked pyrrolidin-3-yl, pyrrolidin-3-ylamino or related moiety, being inhibitors of p38 MAP kinase, are accordingly of use in medicine, for example in the treatment and/or prevention of immune or inflammatory disorders.

  一系列在2位被羰基或磺酰基连接的吡咯烷-3-基，吡咯烷-3-基氨基或相关基团取代的噻吩[2,3-b]吡啶-6(7H)-酮衍生物是p38 MAP激酶的抑制剂，因此在医学上有用，例如在治疗和/或预防免疫或炎症性疾病方面。
• EP1567642A4
  申请人：——

  公开号：EP1567642A4

  公开（公告）日：2006-02-08
• POLYNUCLEOTIDE ENCODING A NOVEL CYSTEINE PROTEASE OF THE CALPAIN SUPERFAMILY, CAN-12, AND VARIANTS THEREOF
  申请人：Bristol-Myers Squibb Company

  公开号：EP1567642A2

  公开（公告）日：2005-08-31
• [EN] POLYNUCLEOTIDE ENCODING A NOVEL CYSTEINE PROTEASE OF THE CALPAIN SUPERFAMILY, CAN-12, AND VARIANTS THEREOF<br/>[FR] POLYNUCLEOTIDE CODANT POUR UNE NOUVELLE CYSTEINE PROTEASE DE LA SUPERFAMILLE CALPAIN, CAN-12 ET LEURS VARIANTES
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2002088303A2

  公开（公告）日：2002-11-07

  The present invention provides novel polynucleotides encoding CAN-12 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding variants of CAN-12 polypeptides, CAN-12v1 and CAN-12v2. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel CAN-12, CAN-12v1, and CAN-12v2 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly neuro- and musculo-degenerative conditions. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
• [EN] THIENOPYRIDONE DERIVATIVES AS KINASE INHIBITORS<br/>[FR] DERIVES DE THIENOPYRIDONE EN TANT QU'INHIBITEURS DE KINASE
  申请人：CELLTECH R&D LTD

  公开号：WO2004113348A1

  公开（公告）日：2004-12-29

  A series of thieno[2,3-b]pyridin-6(7H)-one derivatives, substituted in the 2-position by a carbonyl- or sulfonyl-linked pyrrolidin-3-yl, pyrrolidin-3-ylamino or related moiety, being inhibitors of p38 MAP kinase, are accordingly of use in medicine, for example in the treatment and/or prevention of immune or inflammatory disorders.

  一系列在2位被羰基或磺酰基连接的吡咯烷-3-基、吡咯烷-3-氨基或相关基团取代的噻吩[2,3-b]吡啶-6(7H)-酮衍生物，作为p38 MAP激酶的抑制剂，在医学上具有用途，例如在治疗和/或预防免疫或炎症性疾病方面。